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Blood-Brain Barrier Dysfunction in
Acute Lead Encephalopathy: A
Reappraisal
by Thomas W. Bouldin,* Paul Mushak,* Lorcan A.
O'Tuama, and Martin R. Krigman*
Acute lead encephalopathy was induced in adult guinea pigs by administering daily
oral doses oflead carbonate. During the development ofthe encephalopathy, the structural
and functional integrity of the blood-brain barrier was evaluated with electron
microscopy and tracer probes. Blood, cerebral gray matter, liver, and kidney were
analyzed for lead, calcium, and magnesium content.
The animals regularly developed an encephalopathy after four doses of lead. There
were no discernible pathomorphologic alterations in the cerebral capillaries or perivascu-
lar glial sheaths. Furthermore, no evidence of blood-brain barrier dysfunction was
demonstrated with Evans blue-albumin complex or horseradish peroxidase. Blood-brain
barrier permeability to radiolead was not increased in the intoxicated animals. During the
development ofthe encephalopathy there was a progressive rise in the lead concentration
in all tissues. Concurrently, there was a significant rise in brain calcium.
These results suggest that the encephalopathic effects oflead may be mediated directly
at the neuronal level.
Introduction
The vulnerability of the nervous system to lead
is well known; however, the pathogenesis of lead
encephalopathy remains a vexing problem. Based
upon clinical and experimental studies, a number
of investigators (1-6) have concluded that the en-
cephalopathic effects of lead are mediated through
a primary vascular lesion and a concomitant
blood-brain barrier dysfunction. This conclusion
is based upon the presence of electron-dense
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vacuoles in perivascular astrocytic end-feet and en-
dothelial hyperplasia in experimental and clinical
cases of lead encephalopathy (3, 5). Moreover,
perivascular hemorrhages, cerebral edema, and
blood-brain barrier dysfunction as evaluated by
macromolecular tracers are prominent features of
the encephalopathy in the suckling rat model of
Pentschew and Garro (2, 3). Despite the existence
ofthese cerebral vascular alterations in lead intox-
ication, the direct neural effects of lead must also
be considered as a factor in the pathogenesis oflead
encephalopathy. Evidence is accumulating that
lead ions can directly affect synaptic transmission
(7). Moreover, it has been previously shown that
when lead ions are directly instilled into the
cerebrospinal fluid ofdogs, the animals develop an
encephalopathy and ultimately die (8, 9).
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role of blood-brain barrier dysfunction in the
genesis of acute lead encephalopathy in the adult
guinea pig. The model used was initially described
by Popow (10) in 1885 and more fully by Weller
(11) in 1927. Four consecutive daily oral doses of
lead carbonate (155 mg) produce an encephalopa-
thy in the adult guinea pig characterized by tonic-
clonic seizures. When five consecutive daily doses
of lead are given, all of the animals develop
seizures and die. Despite the development of this
severe encephalopathy, these animals show no
morphological changes in the structures of the
blood-brain barrier, and the permeability of the
barrier to macromolecules is not increased.
Materials and Methods
Experimental Model
Random-bred, adult, male guinea pigs, weighing
475-800 g, were maintained in individual plastic
cages with an ambient temperature of 68°F, 12 hr
of artificial light per day, and fed guinea pig chow
and tap water,adlibitum. A single, daily, oral dose
of 155 mg of lead carbonate in a gelatin capsule
was administered to the experimental animals.
[The dosage is arbitrary and was used by Weller
(11) because it produced an encephalopathy.]
Morphologic Evaluation of
Blood-Brain Barrier with Evans Blue
and Horseradish Peroxidase
The guinea pigs were sacrificed 24 hr after two
(three animals), three (four animals), five (six
animals), or six (two animals) consecutive daily
doses. Two of the five-dose animals also received
Evans blue (5 mg/ml saline), intraperitoneally, 24
hr prior to sacrifice. After pentobarbital anesthesia
(3.6 mg/100 g body weight, intramuscularly), the
animals received an intravascular injection of Sig-
ma type II horseradish peroxidase (25 mg/100 g
body weight, dissolved in 3 ml physiologic saline)
and were sacrificed 10-15 min later by decapita-
tion or intravascular perfusion. For perfusion, the
animals were mechanically ventilated while the
thorax was opened and the ascending aorta was
cannulated via the heart. The brains were perfused
with Karnovsky's dialdehyde fixative (12) diluted
(1:3) with 0.1M sodium cacodylate buffer (pH 7.4)
for 15 min at a pressure of 100 cm of fixative. The
perfused brains and the brains from the decapi-
tated animals were removed, coronally sectioned
through the neostriatum, mamillary bodies, and
midbrain and cerebellum, and fixed by immersion
for 2-4 hr at room temperature in full strength
Karnovsky's fixative. These fixed tissues were then
washed overnight in O.1M sodium cacodylate
buffer, pH 7.2, at 4°C. For light microscopy, 20 ,um
coronal sections of brain were cut with a freezing
microtome; for electron microscopy, 70 um slices of
cerebral cortex and cerebellum were cut with a
Smith-Farquhar tissue chopper. Peroxidase ac-
tivity in the frozen sections and tissue slices was
identified by using the method ofGraham and Kar-
novsky (13). Frozen sections were also mounted in
glycerol for the identification of Evans blue by
fluorescence microscopy. Following incubation in
the Graham-Karnovsky medium, the 70 Am slices
were postfixed in 1% osmium tetroxide in O.1M
cacodylate buffer for 1 hr, stained en bloc with 1%
uranyl acetate in 0.1 M maleate at pH 5.4 for 1 hr,
dehydrated with graded ethanol and finally with
propylene oxide, and embedded in Epon 812.
Survey thick sections were stained with toluidine
blue. Ultrathin sections, either unstained or doubly
stained with uranyl acetate and lead citrate, were
examined in a JEM-T7 electron microscope. Brain
tissue was also prepared for conventional light
microscopy by embedding in paraffin, sectioning at
6-8 ,m, and staining with hematoxylin and eosin
or Luxol fast blue-periodic acid-Schiff stains.
Control guinea pigs did not receive lead carbo-
nate, but did receive intravascular horseradish
peroxidase 15 min prior to vascular brain perfu-
sion. Tissue was processed for light and electron
microscopy as previously described.
Penetration of Tracer Amounts of
Radioactive Lead (21OPb) into Brain
The methodology is as previously described
elsewhere (14). In brief, control and experimental
groups of animals were prepared as described
above under experimental methods. 21OPb (in ap-
proximately 3N HNO3; 60 mCi/mg of lead), 0.01
mCi/kg, was injected into a cannula inserted in the
internal jugular vein. Blood samples were taken at
5, 60, 120, and 240 min after the tracer injection.
The samples were diluted with saline to 1 ml and
counted for 210Pb. Blood samples of 0.5 ml were
taken for total lead estimation.
Tissue Analyses for Lead, Calcium,
and Magnesium
Lead-treated guinea pigs were sacrificed by
decapitation 24 hr after one (four animals), three
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lead; four control animals were also studied.
Blood, cerebral gray matter, liver, and kidney were
analyzed for lead, calcium, and magnesium. Tissue
homogenates and whole blood were analyzed for
lead by the Delves cup microabsorption spectro-
photometric technique (15) as modified by Ediger
and Coleman (16). The samples were analyzed
directly without predigestion in a Perkin-Elmer
atomic absorption spectrophotometer equipped
with a deuterium arc. Calcium and magnesium
were also measured by atomic absorption
spectroscopy. Each of the values reported is the
average ofthree sample determinations.
Results
The guinea pigs began showing symptoms of in-
toxication after two to three doses of lead. These
symptoms included an increased startle response
and decreased food consumption. By the fifth dose
the animals were obtunded, with a greatly in-
creased startle response, and occasional seizures.
Tonic-clonic seizures occurred in three of the
animals studied for morphologic alterations in the
blood-brain barrier. Examination ofthe histologic
preparations by light microscopy revealed no
demonstrable changes in the central nervous
system. There were also no signs of hemorrhage.
Macromolecular Tracer Studies
Macroscopic examination of the brains of lead-
poisoned animals revealed no abnormal staining of
the neural tissue by Evans blue. By fluorescence
and light microscopy, the red fluorescence of the
Evans blue and the brown reaction product of the
horseradish peroxidase were limited to the vascu-
lar lumina except for the choroid plexus and tuber
cinereum-areas which normally have no
blood-brain barrier to these macromolecules (Fig.
1.).
By electron microscopy, the capillary en-
dothelium oflead-poisoned animals (Fig. 2) was in-
distinguishable from that of control animals. The
endothelial cells had a normal complement of
organelles and no increased numbers ofvacuoles or
pinocytotic vesicles. The perithelial cells, basement
membranes, and perivascular glial end-feet were
normal in the lead-poisoned animals. Intracellular
and extracellular edema were not apparent at any
time in the intoxicated animals. The electron-dense
reaction product was limited to capillary lumina
(Fig. 3), and did not extend beyond interen-
FIGURE 1. Macrophotograph of coronal section of brain from
animal receiving 5 daily doses of lead and a single in-
travascular injection of horseradish peroxidase (HRP) 15
min prior to sacrifice. Reaction product of HRP is limited to
the neuropil ofthe tuber cinereum (arrow). Nissl stain. x 14.
dothelial cell zonulae occludentes. Reaction pro-
duct was not observed within pericapillary base-
ment membranes or the extracellular space of the
brain. Examination of the choroid plexus revealed
reaction product within capillary lumina,
perivascular stroma, and in the lateral intercellu-
lar spaces between choroidal epithelial cells (Fig.
4). Reaction product did not pass through choroi-
dal epithelial zonulae occludentes to the ventricu-
lar surface.
Radiolead Levels in Blood and Brain
Constant levels of 2lOPb were achieved in blood
and brain within 5 min of intravenous injection of
radiolead. Despite a 13-fold increase in total blood
lead and a 3-fold increase in total brain lead levels
in the encephalopathic animals, the concentration
of 2lOPb in whole brain was not significantly
different in the two groups (Table 1). Levels of 2lOPb
December 1975 83Fw(uiti- 2. Electron photomicrograph ofcerebellar capillary from animal receiving five daily doses oflead and a single intravascu-
lar dose of HRP 15 min prior to perfusion-fixation. There is no evidence ofreaction product in the capillary basement membrane
or surrounding extracellular space. The capillary endothelium and surrounding neuropil show no pathomorphologic alterations.
Particulate material within vascular lumen is a perfusion artifact. Uranyl acetate and lead citrate. x9500.
in cerebellum in control and in poisoned animals
averaged 1.5 times those found in whole brain.
Table 1. Total and radioactive lead in blood and brain 5
min after pulse injection (O.OlmCi/kg 2lOPb IV).'
Brain
Blood lead, Lead, Radiolead
tgIg pgIg (210Pb), cpm/g
Control 10.54 ± 1.77 0.26 ± 0.03 89 ± 26
(5) (6) (9)
Lead- 132.74 ± 40.8 0.72 ± 0.10 116 ± 105
poisoned (7) (4) (3)
aValues indicate means ± S. D. Numbers ofexperiments are
in parentheses.
Tissue Analysis for Lead, Calcium,
and Magnesium
The results ofthesetissue analyses are presented
in Table 2. There was a progressive rise in lead con-
centration in all of the tissues analyzed. This rise
was most marked after the fifth lead dose, par-
ticularly in the cerebral gray matter. Cerebral
tissue also accumulated calcium and magnesium
during the course of the lead intoxication. In con-
trast, the calcium and magnesium blood levels
were constant throughout this interval. The liver
and kidney level of these cations varied in no
definable pattern but the variance rose. This may
indicate an early perturbation in calcium metabol-
ism.
Environmental Health Perspectives 84Fiu(;111E 3. Electron photomicrograph ofcerebellar capillary from animal receiving five daily doses oflead, and a single intravascu-
lar dose of HRP 15 min prior to sacrifice. Fixation was by immersion. HRP reaction product is limited to the vascular lumen and
is not present within the basement membrane or surrounding extracellular space. Uranyl acetate and lead citrate. x30,000.
Discussion
We found no morphologic or functional evidence
of an altered blood-brain barrier in lead-poisoned
guinea pigs. The structure ofthe cerebral capillary
endothelium, basement membrane, and perivascu-
lar glial sheath in poisoned animals was in-
distinguishable from that found in controls. This
morphologic evidence for the integrity of the
blood-brain barrier in acute lead encephalopathy
was strongly supported by the failure of the
macromolecules horseradish peroxidase and Evans
blue-albumin complex to pass beyond the cerebral
capillary endothelium or the zonulae occludentes
of the choroidal epithelium (17). The absence of
cerebral edema as evaluated morphologically,
further supports the existence of an intact
blood-brain barrier.
These observations indicate that convincing
clinical and chemical lead encephalopathy can oc-
cur without any demonstrable change in
blood-brain barrier morphology or permeability.
The findings are therefore inconsistent with the
suggestion that lead induces an encephalopathy
through a primary vascular alteration as postul-
ated by Pentschew and others (1-6). The absence
ofvascular alterations in lead-poisoned guinea pigs
contrasts sharply with the prominent vascular le-
sions in lead-poisoned suckling rats. Since these
vascular lesions can only be induced in suckling
rats during the first 2 weeks oflife (M. R. Krigman,
unpublished results), one might theorize that the
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85FIGURE 4. Choroid plexus from animal receiving five daily doses oflead and a single intravascular dose ofHRP 15 min prior to per-
fusion-fixation. The floccular HRP reaction product is present within the pericapillary stroma (P) and lateral intercellular space
(arrow) between two choroidal epithelial cells, but is not present on the microvilli (M) projecting into the ventricle. Uranyl acetate
and lead citrate. x11,000.
immature, proliferating capillaries of the suckling
rat are vulnerable to the toxic effects of lead. Sup-
porting thisthesisisthe recent observation that sig-
nificant capillary endothelial cell damage also oc-
curs inthe developing chickembryo exposed to lead
(18). These contrasting data from different animal
models suggestthatin acute lead poisoning one can
delineate within the central nervous system two
loci minoris resistentiae: the neuron and the
proliferating endothelial cell.
The adult guinea pigmodel oflead encephalopa-
thy has much in common with the acute en-
cephalopathy of man. The symptomatology of the
lead-poisoned guinea pigs closely resembles the ob-
tundation and seizures noted in humans with acute
lead encephalopathy. Although the patho-
morphologic changes in the guinea pig brains
are minimal and nonspecific, such minimal
changes are occasionally the only pathologic find-
ings in human cases of acute lead encephalopathy.
As emphasized by Pentschew (1), cerebral edema is
not invariably associated with human lead en-
cephalopathy. In 20 necropsied cases of human
lead encephalopathy reviewed by Pentschew, only
six had a conspicuous increase in brain volume and
three had no gross or microscopic brain changes
(1).
By arguing against a primary vasculopathy in
lead encephalopathy, our results must revive the
hypothesis that the encephalopathic effects of lead
Environmental Health PerspectivesTable 2. Tissue concentration of metals in selected organs during the course of lead intoxication.
No. of doses Metal level,/.tg/g wetweightb
Tissue ofleada Lead Caldum Magnesium
Cerebral gray matter 0 0.17 ± 0.12 0.91 ± 0.55 1.8 ± 0.61
1 0.59 + 0.23 1.3 ± 0.43 2.0 ± 0.52
3 1.3 ± 0.62 1.5 ± 0.51 2.4 ± 0.71
5 3.8 ± 1.8 1.6 ± 0.60 2.3 ± 0.56
Kidney 0 5.8 + 2.1 1.8 ± 0.20 1.6 ± 0.04
1 73 14 1.3 0.30 1.3 0.13
3 137 ± 48 1.3 ± 0.24 1.3 ± 0.22
5 556 ± 51 1.2 ± 0.20 1.8 ± 0.62
Liver 0 2.1 ± 1.8 1.2 ± 0.03 1.2 + 0.06
1 49 ± 2.1 1.2 ± 0.33 1.0 + 0.22
3 65 41 1.2 0.13 1.3 0.10
5 132 34 2.1 1.2 1.6 0.61
Blood 0 0.08 ± 0.02 42.0 ± 0.94 6.2 ± 0.40
1 0.61 ± 0.16 43 ± 0.64 6.0 ± 0.28
3 1.3 0.74 43 0.55 5.7 0.46
5 1.6 ± 0.62 43 ± 0.44 5.8 ± 0.24
aLead carbonate, 155 mg oral dose.
bMetal level in blood,,ug/ml.
are mediated at the neuronal level. Recent studies
demonstrate fundamental neural alterations
directly induced by lead. Bull et al. (19) reported
that lead chloride interferes with the potassiumn-
stimulated respiration of rat cerebral cortex slices,
and Nathanson et al. (20) found that even low con-
centrations of lead inhibit brain adenyl cyclase in
vitro. Lead has also been found (7) to inhibit com-
petitively the calcium-mediated release of
neurotransmitters from presynaptic nerve ter-
minals ofthe bullfrog sympathetic ganglia studied
in vitro.
The radiolead data show that, although the net
flux of lead across the blood-brain barrier is in-
creased in lead encephalopathy, the permeability
coefficient of 21OPb is approximately the same in
control and poisoned animals. This indicates that
acute lead poisoning does not reveal a saturable
process which might serve to limit lead uptake in
the face of acute overdosage. This conclusion is
supported by the failure of lead encephalopathy to
produce structural changes in the cerebral
capillary-glial complex which is the putative site
of carrier-dependent passage of small molecules
from blood into brain. Our findings leave open for
further study two important and related problem
areas: (a) the forces governing unidirectional up-
take of tracer amounts of lead in the normal brain
and (b) the possible effects oflead poisoning on the
metabolism and transport of other physiologically
important cations such as calcium and magnesium.
Some information on the latter issue is provided
by the elevated brain calcium and magnesium
levels found in the poisoned animals. Hoffman and
Weber (21) have also reported elevated brain
calcium levels in lead-poisoned rats, even after a
single dose of lead and after parathyroidectomy.
Unfortunately, these investigators did not measure
magnesium levels. While the mechanisms for the
progressive rise in these cations are unknown, the
accumulation of calcium may be related to an
altered transport system. From in vitro experi-
ments it appears that calcium enters the central
nervous system passively and istransported out ac-
tively (22). The progressive accumulation of brain
calcium observed in this study in the presence of a
constant blood level suggests the efflux of this ca-
tion may be reduced due to a disturbance of an ac-
tive efflux mechanism for calcium. An alternative
possibility is competition by lead for binding sites
on molecules involved in the active efflux of
calcium from the brain. The recent report of lead-
induced inhibition ofadenyl cyclase is ofspecial in-
terest because of the close interrelationship be-
tween cyclic adenosine 3',5'-monophosphate and
calcium (23).
In summary, we have demonstrated that lead
can enter the central nervous system and produce a
severe and fatal encephalopathy in the adult
guinea pig without morphologic alterations of the
blood-brain barrier or demonstrable dysfunction
of this barrier to macromolecules. Thus in this ex-
perimental model the encephalopathic effects of
lead may well be directly mediated at the cellular
level. This does not mean that lead does not pro-
duce a vasculopathy in susceptible species. We do,
December 1975 87however, raise the question as to how much such
vascular . lesions contribute to the acute en-
cephalopathy associated with lead intoxication.
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